Periodontitis is a dysbiotic inflammatory disease with an adverse impact on systemic health. Recent studies have provided insights into the emergence and persistence of dysbiotic oral microbial communities that can mediate inflammatory pathology at local as well as distant sites. This Review discusses the mechanisms of microbial immune subversion that tip the balance from homeostasis to disease in oral or extra-oral sites.
Periodontitis is a dysbiotic oral disease that increases the patients' risk of developing systemic inflammatory disorders. The dysbiosis of the periodontal microbiota is characterized by an imbalance in the relative abundance or influence of microbial species with distinct roles that converge to shape a pathogenic microbial community.
Within the community, periodontal bacteria use sophisticated strategies to evade immune-mediated killing while promoting a nutritionally favourable inflammatory response. The host response is initially subverted by keystone pathogens with the aid of accessory pathogens and is subsequently overactivated by the emerging pathobionts, which leads to destructive inflammation.
Periodontal bacteria (including Porphyromonas gingivalis) have been detected in circulating leukocytes and in aortic tissues, where clinical and mechanistic animal-model studies indicate that they act as pro-atherogenic stimuli.
P. gingivalis expresses a unique citrullinating enzyme that is involved in the generation of autoantibodies that contribute to the pathogenesis of rheumatoid arthritis.
Bacteria that originate from the periodontal tissue (such as Fusobacterium nucleatum) have been detected in the placenta, where they can cause adverse pregnancy outcomes, as suggested by clinical and mechanistic evidence. The periodontal biofilm also acts as a reservoir for respiratory infections and for exacerbations of chronic obstructive pulmonary disease in synergy with local opportunistic pathogens.
Understanding how oral pathogens subvert the host response at the molecular level will not only provide insights into the pathogenesis of periodontitis and associated systemic conditions, but could also reveal new therapeutic targets.
Subscribe to Journal
Get full journal access for 1 year
only $22.08 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Pihlstrom, B. L., Michalowicz, B. S. & Johnson, N. W. Periodontal diseases. Lancet 366, 1809–1820 (2005).
Adler, C. J. et al. Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions. Nature Genet. 45, 450–455 (2013).
Eke, P. I., Dye, B. A., Wei, L., Thornton-Evans, G. O. & Genco, R. J. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J. Dent. Res. 91, 914–920 (2012).
Genco, R. J. & Van Dyke, T. E. Prevention: reducing the risk of CVD in patients with periodontitis. Nature Rev. Cardiol. 7, 479–480 (2010).
Lundberg, K., Wegner, N., Yucel-Lindberg, T. & Venables, P. J. Periodontitis in RA — the citrullinated enolase connection. Nature Rev. Rheumatol. 6, 727–730 (2010).
Kebschull, M., Demmer, R. T. & Papapanou, P. N. “Gum bug leave my heart alone”: epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res. 89, 879–902 (2010).
Whitmore, S. E. & Lamont, R. J. Oral bacteria and cancer. PLoS Pathog. 10, e1003933 (2014).
Han, Y. W. & Wang, X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J. Dent. Res. 92, 485–491 (2013).
Madianos, P. N., Bobetsis, Y. A. & Offenbacher, S. Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms. J. Clin. Periodontol. 40, S170–S180 (2013).
Socransky, S. S. & Haffajee, A. D. Periodontal microbial ecology. Periodontol. 2000 38, 135–187 (2005).
Abusleme, L. et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 7, 1016–1025 (2013). This metagenomic study characterizes ecological events in the subgingival microbial communities that underpin the development of periodontitis, and elucidates the relationship between inflammation and the disease-associated microbiome.
Griffen, A. L. et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 6, 1176–1185 (2012).
Jorth, P. et al. Metatranscriptomics of the human oral microbiome during health and disease. MBio 5, e01012–e01014 (2014).
Dewhirst, F. E. et al. The human oral microbiome. J. Bacteriol. 192, 5002–5017 (2010). This study led to the Human Oral Microbiome Database and was the first curated description of a human body-site-specific microbiome.
Hajishengallis, G. et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10, 497–506 (2011). This paper provides in vivo evidence showing that a single microorganism that acts as a keystone pathogen can cause quantitative and qualitative alterations to the commensal microbiota, which in turn leads to dysbiosis.
Hajishengallis, G., Darveau, R. P. & Curtis, M. A. The keystone-pathogen hypothesis. Nature Rev. Microbiol. 10, 717–725 (2012).
Darveau, R. P. Periodontitis: a polymicrobial disruption of host homeostasis. Nature Rev. Microbiol. 8, 481–490 (2010).
Rosier, B. T., de Jager, M., Zaura, E. & Krom, B. P. Historical and contemporary hypotheses on the development of oral diseases: are we there yet? Front Cell Infect. Microbiol. 4, 92 (2014).
Hajishengallis, G. & Lamont, R. J. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol. Oral Microbiol. 27, 409–419 (2012).
Hajishengallis, G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends Immunol. 35, 3–11 (2014).
Han, Y. W. et al. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet. Gynecol. 115, 442–445 (2010).
Heo, S. M., Haase, E. M., Lesse, A. J., Gill, S. R. & Scannapieco, F. A. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoalveolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin. Infect. Dis. 47, 1562–1570 (2008).
Scannapieco, F. A. Individuals with chronic obstructive pulmonary disease (COPD) may be more likely to have more severe periodontal disease than individuals without COPD. J. Evid. Based Dent. Pract. 14, 79–81 (2014).
Tan, L., Wang, H., Li, C. & Pan, Y. 16S rDNA-based metagenomic analysis of dental plaque and lung bacteria in patients with severe acute exacerbations of chronic obstructive pulmonary disease. J. Periodont. Res. 49, 760–769 (2014).
Kozarov, E. V., Dorn, B. R., Shelburne, C. E., Dunn, W. A. Jr & Progulske-Fox, A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25, e17–e18 (2005).
Haraszthy, V. I., Zambon, J. J., Trevisan, M., Zeid, M. & Genco, R. J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71, 1554–1560 (2000).
Carrion, J. et al. Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J. Immunol. 189, 3178–3187 (2012). This study combines clinical and mechanistic evidence implicating blood myeloid DCs as transport vehicles for the systemic dissemination of P. gingivalis from its oral habitat.
Velsko, I. M. et al. Active invasion of oral and aortic tissues by Porphyromonas gingivalis in mice causally links periodontitis and atherosclerosis. PLoS ONE 9, e97811 (2014).
Slocum, C. et al. Distinct lipid A moieties contribute to pathogen-induced site-specific vascular inflammation. PLoS Pathog. 10, e1004215 (2014). This study shows that the ability of P. gingivalis to enzymatically modify the lipid A moiety of its lipopolysaccharide allows it to escape from TLR4-mediated immunity and persist while inducing atherogenic inflammation at sites distant from the initial infection site.
Maresz, K. J. et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 9, e1003627 (2013). This study was the first to provide an in vivo mechanistic link between P. gingivalis PPAD and rheumatoid arthritis associated with ACPAs.
Wegner, N. et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheumatol. 62, 2662–2672 (2010).
Mikuls, T. R. et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 66, 1090–1100 (2014).
Koziel, J., Mydel, P. & Potempa, J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr. Rheumatol. Rep. 16, 408 (2014).
Perez-Chaparro, P. J. et al. Newly identified pathogens associated with periodontitis: a systematic review. J. Dent. Res. 93, 846–858 (2014).
Sima, C. & Glogauer, M. Neutrophil dysfunction and host susceptibility to periodontal inflammation: current state of knowledge. Curr. Oral Health Rep. 1, 95–103 (2014).
Nussbaum, G. & Shapira, L. How has neutrophil research improved our understanding of periodontal pathogenesis? J. Clin. Periodontol. 38, 49–59 (2011).
Yilmaz, O. The chronicles of Porphyromonas gingivalis: the microbium, the human oral epithelium and their interplay. Microbiology 154, 2897–2903 (2008).
Darveau, R. P. Porphyromonas gingivalis neutrophil manipulation: risk factor for periodontitis? Trends Microbiol. 22, 428–429 (2014).
Bostanci, N. & Belibasakis, G. N. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol. Lett. 333, 1–9 (2012).
Holt, S. C., Ebersole, J., Felton, J., Brunsvold, M. & Kornman, K. S. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239, 55–57 (1988).
Darveau, R. P., Hajishengallis, G. & Curtis, M. A. Porphyromonas gingivalis as a potential community activist for disease. J. Dent. Res. 91, 816–820 (2012).
Maekawa, T. et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe 15, 768–778 (2014). This investigation mechanistically dissects how periodontal bacteria can interfere with immune-mediated killing while promoting a nutritionally favourable inflammatory response, thereby perpetuating dysbiosis.
Hajishengallis, G. & Lamont, R. J. Breaking bad: manipulation of the host response by Porphyromonas gingivalis. Eur. J. Immunol. 44, 328–338 (2014).
Jiao, Y. et al. Induction of bone loss by pathobiont-mediated nod1 signaling in the oral cavity. Cell Host Microbe 13, 595–601 (2013). This study demonstrates the concept of commensal-turned-pathobiont in periodontitis under conditions of disrupted tissue homeostasis.
Whitmore, S. E. & Lamont, R. J. The pathogenic persona of community-associated oral streptococci. Mol. Microbiol. 81, 305–314 (2011).
Haffajee, A. D. et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J. Clin. Periodontol. 25, 346–353 (1998).
Kesavalu, L. et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect. Immun. 75, 1704–1712 (2007).
Daep, C. A., Novak, E. A., Lamont, R. J. & Demuth, D. R. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect. Immun. 79, 67–74 (2011).
Orth, R. K., O'Brien-Simpson, N. M., Dashper, S. G. & Reynolds, E. C. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol. Oral Microbiol. 26, 229–240 (2011).
Polak, D. et al. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J. Clin. Periodontol. 36, 406–410 (2009).
Tan, K. H. et al. Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog. 10, e1003955 (2014).
Amano, A. et al. Genetic characteristics and pathogenic mechanisms of periodontal pathogens. Adv. Dent. Res. 26, 15–22 (2014).
Kuboniwa, M. et al. Insights into the virulence of oral biofilms: discoveries from proteomics. Expert Rev. Proteom. 9, 311–323 (2012).
Cyktor, J. C. & Turner, J. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect. Immun. 79, 2964–2973 (2011).
Hajishengallis, G. The inflammophilic character of the periodontitis-associated microbiota. Mol. Oral Microbiol. 29, 248–257 (2014).
Hajishengallis, E. & Hajishengallis, G. Neutrophil homeostasis and periodontal health in children and adults. J. Dent. Res. 93, 231–237 (2014).
Moutsopoulos, N. M. et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17–driven inflammatory bone loss. Sci. Transl. Med. 6, 229ra240 (2014).
Ryder, M. I. Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol. 2000 53, 124–137 (2010).
Chapple, I. L. & Matthews, J. B. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol. 2000 43, 160–232 (2007).
Eskan, M. A. et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunol. 13, 465–473 (2012).
Lee, W., Aitken, S., Sodek, J. & McCulloch, C. A. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodon. Res. 30, 23–33 (1995).
Hernandez, M. et al. Associations between matrix metalloproteinase-8 and -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis: a longitudinal study. J. Periodontol. 81, 1644–1652 (2010).
Landzberg, M., Doering, H., Aboodi, G. M., Tenenbaum, H. C. & Glogauer, M. Quantifying oral inflammatory load: oral neutrophil counts in periodontal health and disease. J. Periodont. Res. http://dx.doi.org/10.1111/jre.12211 (2014).
Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nature Immunol. 11, 785–797 (2010).
Popadiak, K., Potempa, J., Riesbeck, K. & Blom, A. M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 178, 7242–7250 (2007).
Jusko, M. et al. A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system. J. Immunol. 188, 2338–2349 (2012).
Potempa, M. et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. PLoS Pathog. 5, e1000316 (2009).
Miller, D. P. et al. Structure of factor H-binding protein B (FhbB) of the periopathogen, Treponema denticola: insights into progression of periodontal disease. J. Biol. Chem. 287, 12715–12722 (2012).
Malm, S. et al. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia. PLoS ONE 7, e34852 (2012).
Liang, S. et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol. 186, 869–877 (2011).
Burns, E., Bachrach, G., Shapira, L. & Nussbaum, G. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J. Immunol. 177, 8296–8300 (2006).
Myneni, S. R. et al. TLR2 signaling and Th2 responses drive Tannerella forsythia-induced periodontal bone loss. J. Immunol. 187, 501–509 (2011).
Shin, J. E., Baek, K. J., Choi, Y. S. & Choi, Y. A periodontal pathogen Treponema denticola hijacks the Fusobacterium nucleatum-driven host response. Immunol. Cell Biol. 91, 503–510 (2013).
Wang, M. et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci. Signal. 3, ra11 (2010).
Taxman, D. J. et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J. Biol. Chem. 287, 32791–32799 (2012).
Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013–1022 (2014).
Moutsopoulos, N. M. et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J. Autoimmun. 39, 294–303 (2012).
Jauregui, C. E. et al. Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect. Immun. 81, 2288–2295 (2013). This study shows that the P. gingivalis -induced local 'chemokine paralysis', which was originally shown to affect innate immunity, also involves the suppression of T H 1-type chemokines.
Hayashi, C. et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J. Immunol. 189, 3681–3688 (2012).
Gemmell, E., Yamazaki, K. & Seymour, G. J. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol. 2000 43, 14–40 (2007).
Gaffen, S. L. & Hajishengallis, G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J. Dent. Res. 87, 817–828 (2008).
Bahekar, A. A., Singh, S., Saha, S., Molnar, J. & Arora, R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J. 154, 830–837 (2007).
Friedewald, V. E. et al. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am. J. Cardiol. 104, 59–68 (2009).
Tonetti, M. S. et al. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 356, 911–920 (2007).
Offenbacher, S. et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J. Periodontol. 80, 190–201 (2009).
Desvarieux, M. et al. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J. Am. Heart Assoc. 2, e000254 (2013).
Brodala, N. et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb. Vasc. Biol. 25, 1446–1451 (2005).
Tonetti, M. S. Periodontitis and risk for atherosclerosis: an update on intervention trials. J. Clin. Periodontol. 36 (Suppl. 10), 15–19 (2009).
Arimatsu, K. et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci. Rep. 4, 4828 (2014).
Gibson, F. C. 3rd et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 2801–2806 (2004).
Jain, A. et al. Role for periodontitis in the progression of lipid deposition in an animal model. Infect. Immun. 71, 6012–6018 (2003).
Zelkha, S. A., Freilich, R. W. & Amar, S. Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol. 2000 54, 207–221 (2010).
Chiu, B. Multiple infections in carotid atherosclerotic plaques. Am. Heart J. 138, S534–S536 (1999).
Reyes, L., Herrera, D., Kozarov, E., Roldan, S. & Progulske-Fox, A. Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology. J. Clin. Periodontol. 40 (Suppl. 14), 30–50 (2013).
Hayashi, C. et al. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J. Innate Immun. 2, 334–343 (2010).
Coats, S. R. et al. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4′- phosphatase activities. Cell. Microbiol. 11, 1587–1599 (2009).
Curtis, M. A. et al. Temperature dependent modulation of Porphyromonas gingivalis lipid A structure and interaction with the innate host defences. Infect. Immun. 79, 1187–1193 (2011).
Al-Qutub, M. N. et al. Hemin-dependent modulation of the lipid A structure of Porphyromonas gingivalis lipopolysaccharide. Infect. Immun. 74, 4474–4485 (2006). References 97 and 98 show, at the molecular level, how environmental factors can influence microbial virulence and host–microorganism interactions.
Zenobia, C. et al. Porphyromonas gingivalis lipid A phosphatase activity is critical for colonization and increasing the commensal load in the rabbit ligature model. Infect. Immun. 82, 650–659 (2014).
Coats, S. R., Do, C. T., Karimi-Naser, L. M., Braham, P. H. & Darveau, R. P. Antagonistic lipopolysaccharides block E. coli lipopolysaccharide function at human TLR4 via interaction with the human MD-2 lipopolysaccharide binding site. Cell. Microbiol. 9, 1191–1202 (2007).
Bostanci, N. et al. Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 39, 147–156 (2007).
Wang, M. et al. Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J. Immunol. 179, 2349–2358 (2007).
Wang, M. & Hajishengallis, G. Lipid raft-dependent uptake, signalling and intracellular fate of Porphyromonas gingivalis in mouse macrophages. Cell. Microbiol. 10, 2029–2042 (2008).
Manes, S., del Real, G. & Martinez, A. C. Pathogens: raft hijackers. Nature Rev. Immunol. 3, 557–568 (2003).
Zeituni, A. E., McCaig, W., Scisci, E., Thanassi, D. G. & Cutler, C. W. The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J. Bacteriol. 192, 4103–4110 (2010).
Zeituni, A. E., Jotwani, R., Carrion, J. & Cutler, C. W. Targeting of DC-SIGN on human dendritic cells by minor fimbriated Porphyromonas gingivalis strains elicits a distinct effector T cell response. J. Immunol. 183, 5694–5704 (2009).
Miles, B. et al. Secondary lymphoid organ homing phenotype of human myeloid dendritic cells disrupted by an intracellular oral pathogen. Infect. Immun. 82, 101–111 (2014).
Liang, Z. et al. Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65, 967–971 (2005).
Sainz, J. & Sata, M. CXCR4, a key modulator of vascular progenitor cells. Arterioscler. Thromb. Vasc. Biol. 27, 263–265 (2007).
Belstrom, D. et al. The atherogenic bacterium Porphyromonas gingivalis evades circulating phagocytes by adhering to erythrocytes. Infect. Immun. 79, 1559–1565 (2011).
Madrigal, A. G., Barth, K., Papadopoulos, G. & Genco, C. A. Pathogen-mediated proteolysis of the cell death regulator RIPK1 and the host defense modulator RIPK2 in human aortic endothelial cells. PLoS Pathog. 8, e1002723 (2012).
Huck, O., Elkaim, R., Davideau, J. L. & Tenenbaum, H. Porphyromonas gingivalis-impaired innate immune response via NLRP3 proteolysis in endothelial cells. Innate Immun. 21, 65–72 (2014).
Harokopakis, E., Albzreh, M. H., Martin, M. H. & Hajishengallis, G. TLR2 transmodulates monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J. Immunol. 176, 7645–7656 (2006).
Takahashi, Y. et al. Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells. Cell. Microbiol. 8, 738–757 (2006).
Jain, S., Coats, S. R., Chang, A. M. & Darveau, R. P. A novel class of lipoprotein lipase-sensitive molecules mediates Toll-like receptor 2 activation by Porphyromonas gingivalis. Infect. Immun. 81, 1277–1286 (2013).
Clark, R. B. et al. Serine lipids of Porphyromonas gingivalis are human and mouse Toll-like receptor 2 ligands. Infect. Immun. 81, 3479–3489 (2013).
Delbosc, S. et al. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS ONE 6, e18679 (2011).
Nakayama, K. Porphyromonas gingivalis cell-induced hemagglutination and platelet aggregation. Periodontol. 2000 54, 45–52 (2010).
Han, Y. W., Houcken, W., Loos, B. G., Schenkein, H. A. & Tezal, M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv. Dent. Res. 26, 47–55 (2014).
Chen, Y. W. et al. Association between periodontitis and anti-cardiolipin antibodies in Buerger disease. J. Clin. Periodontol. 36, 830–835 (2009).
Li, X. Y. et al. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Oncol. Rep. 30, 1329–1336 (2013).
Giacona, M. B. et al. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol. Lett. 241, 95–101 (2004).
Sanz, M. & Kornman, K. Periodontitis and adverse pregnancy outcomes: consensus report of the Joint EFP/AAP workshop on periodontitis and systemic diseases. J. Clin. Periodontol. 40 (Suppl. 14), 164–169 (2013).
Liu, H., Redline, R. W. & Han, Y. W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179, 2501–2508 (2007). This was the first mechanistic study linking an oral pathogen to pregnancy complications in an animal model.
Han, Y. W. et al. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 72, 2272–2279 (2004).
Schenkein, H. A. et al. Anti-cardiolipin antibodies in sera from patients with periodontitis. J. Dent. Res. 82, 919–922 (2003).
Schenkein, H. A., Bradley, J. L. & Purkall, D. B. Anticardiolipin in Porphyromonas gingivalis antisera causes fetal loss in mice. J. Dent. Res. 92, 814–818 (2013). This report implicates molecular mimicry as a mechanism by which the host response to P. gingivalis can induce cardiolipin-specific autoantibodies that cause fetal loss in mice.
Scher, J. U., Bretz, W. A. & Abramson, S. B. Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr. Opin. Rheumatol. 26, 424–429 (2014).
Joseph, R., Rajappan, S., Nath, S. G. & Paul, B. J. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatol. Int. 33, 103–109 (2013).
de Pablo, P., Dietrich, T. & McAlindon, T. E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J. Rheumatol. 35, 70–76 (2008).
Suwannalai, P., Trouw, L. A., Toes, R. E. & Huizinga, T. W. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod. Rheumatol. 22, 15–20 (2012).
Gyorgy, B., Toth, E., Tarcsa, E., Falus, A. & Buzas, E. I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38, 1662–1677 (2006).
Pyrc, K. et al. Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage. Infect. Immun. 81, 55–64 (2013).
Pratesi, F. et al. HLA shared epitope and ACPA: just a marker or an active player? Autoimmun. Rev. 12, 1182–1187 (2013).
Lundberg, K. et al. Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 58, 3009–3019 (2008). This study identifies an immunodominant epitope in citrullinated α-enolase that is cross-reactive with citrullinated P. gingivalis enolase and is implicated in rheumatoid arthritis; hence, these findings are consistent with a role for P. gingivalis and its citrullinating enzyme in priming autoimmunity.
Catrina, A. I., Ytterberg, A. J., Reynisdottir, G., Malmstrom, V. & Klareskog, L. Lungs, joints and immunity against citrullinated proteins in rheumatoid arthritis. Nature Rev. Rheumatol. (2014).
Sokolove, J. et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7, e35296 (2012).
Gully, N. et al. Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS ONE 9, e100838 (2014).
Paju, S. & Scannapieco, F. A. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 13, 508–512 (2007).
Finegold, S. M. Aspiration pneumonia. Rev. Infect. Dis. 13, S737–S742 (1991).
Awano, S. et al. Oral health and mortality risk from pneumonia in the elderly. J. Dent. Res. 87, 334–339 (2008).
Kimizuka, R., Kato, T., Ishihara, K. & Okuda, K. Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections. Microbes Infect. 5, 1357–1362 (2003).
Müller, F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. J. Dent. Res. http://dx.doi.org/10.1177/0022034514552494 (2014).
Iinuma, T. et al. Denture wearing during sleep doubles the risk of pneumonia in the very elderly. J. Dent. Res. http://dx.doi.org/10.1177/0022034514552493 (2014).
Peter, K. P. et al. Association between periodontal disease and chronic obstructive pulmonary disease: a reality or just a dogma? J. Periodontol. 84, 1717–1723 (2013).
Sethi, S. & Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355–2365 (2008).
Pan, Y., Teng, D., Burke, A. C., Haase, E. M. & Scannapieco, F. A. Oral bacteria modulate invasion and induction of apoptosis in HEp-2 cells by Pseudomonas aeruginosa. Microb. Pathog. 46, 73–79 (2009).
Li, Q. et al. Porphyromonas gingivalis modulates Pseudomonas aeruginosa-induced apoptosis of respiratory epithelial cells through the STAT3 signaling pathway. Microbes Infect. 16, 17–27 (2014).
Yao, L. et al. Porphyromonas gingivalis infection sequesters pro-apoptotic BAD through AKT in primary gingival epithelial cells. Mol. Oral Microbiol. 25, 89–101 (2010).
Cannon, C. L., Kowalski, M. P., Stopak, K. S. & Pier, G. B. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator. Am. J. Respir. Cell. Mol. Biol. 29, 188–197 (2003).
Papapanou, P. N. in Oral Microbiology and Immunology (eds Lamont, R. J., Hajishengallis, G. & Jenkinson, H.) 251–271 (ASM Press, 2014).
Kumar, P. S. Smoking and the subgingival ecosystem: a pathogen-enriched community. Future Microbiol. 7, 917–919 (2012).
Stabholz, A., Soskolne, W. A. & Shapira, L. Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis. Periodontol. 2000 53, 138–153 (2010).
Laine, M. L., Crielaard, W. & Loos, B. G. Genetic susceptibility to periodontitis. Periodontol. 2000 58, 37–68 (2012).
Divaris, K. et al. Exploring the genetic basis of chronic periodontitis: a genome-wide association study. Hum. Mol. Genet. 22, 2312–2324 (2013).
Bagaitkar, J. et al. Tobacco smoke augments Porphyromonas gingivalis–Streptococcus gordonii biofilm formation. PLoS ONE 6, e27386 (2011).
Atanasova, K. R. & Yilmaz, O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol. Oral Microbiol. 29, 55–66 (2014).
Castellarin, M. et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299–306 (2012).
Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195–206 (2013). This study generates both mechanistic and clinical evidence implicating the oral bacterium F. nucleatum in colorectal cancer.
Nagy, K. N., Sonkodi, I., Szoke, I., Nagy, E. & Newman, H. N. The microflora associated with human oral carcinomas. Oral Oncol. 34, 304–308 (1998).
Katz, J., Onate, M. D., Pauley, K. M., Bhattacharyya, I. & Cha, S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int. J. Oral Sci. 3, 209–215 (2011).
Ahn, J., Segers, S. & Hayes, R. B. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 33, 1055–1058 (2012).
Michaud, D. S. et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 62, 1764–1770 (2013).
Inaba, H. et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell. Microbiol. 16, 131–145 (2014).
Kuboniwa, M. et al. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 10, 122–128 (2008).
Mao, S. et al. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell. Microbiol. 9, 1997–2007 (2007).
Yilmaz, O. et al. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell. Microbiol. 10, 863–875 (2008).
Iwahori, K. et al. Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma. Int. J. Cancer 129, 993–1005 (2011).
Moffatt, C. E. & Lamont, R. J. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect. Immun. 79, 2632–2637 (2011).
Groeger, S., Domann, E., Gonzales, J. R., Chakraborty, T. & Meyle, J. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 216, 1302–1310 (2011).
Sznol, M. & Chen, L. Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer. Clin. Cancer Res. 19, 1021–1034 (2013).
The author's research is supported by grants from the US National Institutes of Health (DE015254, DE017138, DE021685 and AI068730). The author regrets that several studies could only be cited indirectly through comprehensive reviews, owing to space and reference number limitations.
The author declares no competing financial interests.
A complex and diverse community of microorganisms that live within a given anatomical niche (such as an environmentally exposed surface of a multicellular eukaryotic organism).
A condition that is characterized by an imbalance in the relative abundance or influence of species within a microbial community that is associated with a disease; for instance, periodontitis or inflammatory bowel disease.
A condition of equilibrium or stability in a system that is maintained by adjusting physiological processes to counteract external changes. An example of homeostasis is the balanced relationship between host tissues and the resident microbiota that prevents destructive inflammation or disease.
- Subgingival crevice
Narrow space between the tooth surface and the free gingiva.
- Gingival crevicular fluid
Serum exudate that originates in the gingival capillaries and flows into the gingival crevice carrying locally produced immune and inflammatory mediators such as complement, cytokines and antimicrobial peptides.
- Keystone pathogen
A pathogen with a disproportionately large effect on its environment relative to its abundance; for example, low-abundance P. gingivalis remodels a commensal microbial community into a dysbiotic and disease-provoking microbiota.
Commensal microorganisms with the potential to induce pathology under conditions of disrupted homeostasis.
- Accessory pathogens
Commensal bacteria that are not pathogenic by themselves in a given niche, but that can enhance the virulence of keystone pathogens by, for example, facilitating their colonization or providing metabolic support.
A family of trypsin-like cysteine proteinases that are secreted by P. gingivalis and contribute to its virulence, as well as to the pathogenesis of periodontitis. Members of this family include the high molecular mass arginine-specific gingipain A (HRgpA), the arginine-specific gingipain B (RgpB) and the lysine-specific gingipain (Kgp).
This term refers to bacteria that thrive on inflammation as they feed off inflammatory tissue breakdown products. The literal meaning is 'attracted to inflammation', which is derived from the combined meaning of inflammation and the Greek suffix philic denoting fondness.
- Periodontal pockets
The pathologically deepened subgingival crevices in periodontitis, which are characteristic of the disease.
A cytosolic, multiprotein complex that responds to infection or tissue injury by activating pro-inflammatory caspases (mainly caspase 1), leading to the cleavage and release of pro-inflammatory cytokines (such as interleukin-1β (IL-1β) and IL-18) and under certain conditions, such as when myeloid cells are infected with pathogenic bacteria, leads to pyroptosis, a form of necrotic cell death.
- Non-canonical inflammasome
A caspase-11-dependent pathway of inflammasome activation that is crucial for the control of infections caused by Gram-negative bacteria and can induce cell death (pyroptosis) independently of caspase 1.
Accumulated fatty deposits in the inner lining (intima) of an artery that lead to the restriction of blood flow and an increased risk of thrombosis.
About this article
Cite this article
Hajishengallis, G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol 15, 30–44 (2015) doi:10.1038/nri3785
Shared detection of Porphyromonas gingivalis in cohabiting family members: a systematic review and meta-analysis
Journal of Oral Microbiology (2020)
A bacterial metabolite induces Nrf2-mediated anti-oxidative responses in gingival epithelial cells by activating the MAPK signaling pathway
Archives of Oral Biology (2020)
Preoperative periodontal treatment and its effects on postoperative infection in cardiac valve surgery
Clinical and Experimental Dental Research (2019)
Hematopoietic progenitor cells as integrative hubs for adaptation to and fine-tuning of inflammation
Nature Immunology (2019)
The potentiality of salivary peptide biomarkers for screening patients with periodontal diseases by mass spectrometry
Clinica Chimica Acta (2019)